Takahito Wada

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Venues

Congenital anomalies

Journal of human genetics

Human genome variation

Kyoto University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kyoto University Apr 01 2013

Japan

Associate Professor :: Medical Ethics and medical Genetics

Publications

Hidenori Kawasaki, Takahiro Yamada, Yoshimitsu Takahashi, Takeo Nakayama, Takahito Wada, Shinji Kosugi, null null
Mortality and morbidity of infants with trisomy 21, weighing 1500 grams or less, in Japan. Journal of human genetics 67 (11) (2022)
Karin Kojima, Takahito Wada, Hiroko Shimbo, Takahiro Ikeda, Eriko F Jimbo, Hirotomo Saitsu, Naomichi Matsumoto, Takanori Yamagata
The ATRX splicing variant c.21-1G>A is asymptomatic. Human genome variation 9 (1) (2022)
Yuko Yamaguchi, Takahiro Yamada, Mikako Goto, Hidenori Kawasaki, Takahito Wada, Yasuko Ikeda-Sakai, Yoshiyuki Saito, Masahiro Hayashi, Shiro Tanaka, Ryosuke Takahashi, Takeo Nakayama, Atsuko Murashima, Shinji Kosugi
Analysis of triptan use during pregnancy in Japan: A case series. Congenital anomalies 62 (2) (2022)
Takenori Tozawa, Akira Nishimura, Tamaki Ueno, Akane Shikata, Yoshihiro Taura, Takeshi Yoshida, Naoko Nakagawa, Takahito Wada, Shinji Kosugi, Tomoko Uehara, Toshiki Takenouchi, Kenjiro Kosaki, Tomohiro Chiyonobu
Complex hereditary spastic paraplegia associated with episodic visual loss caused by ACO2 variants. Human genome variation 8 (1) (2021)
Hidenori Kawasaki, Takahiro Yamada, Yoshimitsu Takahashi, Takeo Nakayama, Takahito Wada, Shinji Kosugi, null null
The short-term mortality and morbidity of very low birth weight infants with trisomy 18 or trisomy 13 in Japan. Journal of human genetics 66 (3) (2020)
Hidenori Kawasaki, Takahiro Yamada, Takahito Wada, Shinji Kosugi
Current status and legal/ethical problems in the research use of the tissues of aborted human fetuses in Japan. Congenital anomalies 60 (6) (2020)
Takahito Wada, Shuichi Suzuki, Norifumi Shioda
5-Aminolevulinic acid can ameliorate language dysfunction of patients with ATR-X syndrome. Congenital anomalies 60 (5) (2020)

Takahito Wada.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takahito Wada